Four courses versus eight courses of adjuvant S-1 for patients with stage II gastric cancer (JCOG1104 [OPAS-1]): an open-label, phase 3, non-inferiority, randomised trial.
暂无分享，去创建一个
Kazuhiro Yoshida | T. Yoshikawa | H. Katayama | Takanobu Yamada | S. Nunobe | T. Sano | M. Sasako | S. Ito | T. Yasuda | Y. Nishida | M. Terashima | J. Mizusawa | N. Boku | M. Kaji | Y. Choda | S. Hato | N. Fukushima | A. Takeno | Y. Kawachi | H. Yabusaki | H. Fukuda